2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide

Labetalol; LC-ESI-ITFT; MS2; CE: 40%; R=15000; [M+H]+

Labetalol; LC-ESI-ITFT; MS2; CE: 50%; R=15000; [M+H]+

Labetalol; LC-ESI-ITFT; MS2; CE: 60%; R=15000; [M+H]+

Labetalol; LC-ESI-Q; MS; NEG; 30 V

Labetalol; LC-ESI-Q; MS; POS; 15 V

Labetalol; LC-ESI-Q; MS; POS; 30 V

Labetalol; LC-ESI-Q; MS; POS; 45 V

Labetalol; LC-ESI-Q; MS; POS; 60 V

Labetalol; LC-ESI-Q; MS; POS; 75 V

Labetalol; LC-ESI-Q; MS; POS; 90 V

Labetalol; LC-ESI-QFT; MS2; CE: 15; R=17500; [M+H]+

Labetalol; LC-ESI-QFT; MS2; CE: 15; R=17500; [M-H]-

Labetalol; LC-ESI-QFT; MS2; CE: 30; R=17500; [M+H]+

Labetalol; LC-ESI-QFT; MS2; CE: 30; R=17500; [M-H]-

Labetalol; LC-ESI-QFT; MS2; CE: 35 NCE; R=35000; [M+H]+

Labetalol; LC-ESI-QFT; MS2; CE: 35 NCE; R=35000; [M-H]-

Labetalol; LC-ESI-QFT; MS2; CE: 45; R=17500; [M+H]+

Labetalol; LC-ESI-QFT; MS2; CE: 45; R=17500; [M-H]-

Labetalol; LC-ESI-QFT; MS2; CE: 60; R=17500; [M+H]+

Labetalol; LC-ESI-QFT; MS2; CE: 60; R=17500; [M-H]-

Labetalol; LC-ESI-QFT; MS2; CE: 75; R=17500; [M+H]+

Labetalol; LC-ESI-QFT; MS2; CE: 75; R=17500; [M-H]-

Labetalol; LC-ESI-QFT; MS2; CE: 90; R=17500; [M+H]+

Labetalol; LC-ESI-QFT; MS2; CE: 90; R=17500; [M-H]-

Labetalol; LC-ESI-QTOF; MS2; CE: 10 eV; R=35000; [M+H]+

Labetalol; LC-ESI-QTOF; MS2; CE: 20 eV; R=35000; [M+H]+

Labetalol; LC-ESI-QTOF; MS2; CE: 30 eV; R=35000; [M+H]+

Labetalol; LC-ESI-QTOF; MS2; CE: 40 eV; R=35000; [M+H]+

Labetalol; LC-ESI-QTOF; MS2; CE: 50 eV; R=35000; [M+H]+

Labetalol; LC-ESI-QTOF; MS2; CE: Ramp 22.2-33.3 eV; R=35000; [M+H]+